Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
3.840
-0.150 (-3.76%)
At close: Nov 16, 2026, 4:00 PM EST
3.925
+0.085 (2.20%)
After-hours: Nov 16, 2026, 7:59 PM EST

Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $1.36 billion. The enterprise value is $1.16 billion.

Market Cap1.36B
Enterprise Value 1.16B

Important Dates

The last earnings date was Wednesday, November 4, 2026, after market close.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

Nuvation Bio has 353.02 million shares outstanding. The number of shares has increased by 2.44% in one year.

Current Share Class 352.02M
Shares Outstanding 353.02M
Shares Change (YoY) +2.44%
Shares Change (QoQ) +0.89%
Owned by Insiders (%) 17.43%
Owned by Institutions (%) 64.33%
Float 265.54M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.72
Forward PS 6.26
PB Ratio 5.94
P/TBV Ratio 6.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.75
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.45, with a Debt / Equity ratio of 2.05.

Current Ratio 7.45
Quick Ratio 7.14
Debt / Equity 2.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.70

Financial Efficiency

Return on equity (ROE) is -49.09% and return on invested capital (ROIC) is -12.54%.

Return on Equity (ROE) -49.09%
Return on Assets (ROA) -11.18%
Return on Invested Capital (ROIC) -12.54%
Return on Capital Employed (ROCE) -18.15%
Weighted Average Cost of Capital (WACC) 11.38%
Revenue Per Employee $650,745
Profits Per Employee -$438,497
Employee Count310
Asset Turnover 0.29
Inventory Turnover 2.72

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.99% in the last 52 weeks. The beta is 1.73, so Nuvation Bio's price volatility has been higher than the market average.

Beta (5Y) 1.73
52-Week Price Change -20.99%
50-Day Moving Average 5.07
200-Day Moving Average 5.32
Relative Strength Index (RSI) 29.81
Average Volume (20 Days) 5,259,533

Short Selling Information

The latest short interest is 62.00 million, so 17.56% of the outstanding shares have been sold short.

Short Interest 62.00M
Short Previous Month 58.86M
Short % of Shares Out 17.56%
Short % of Float 23.35%
Short Ratio (days to cover) 10.79

Income Statement

In the last 12 months, Nuvation Bio had revenue of $201.73 million and -$135.93 million in losses. Loss per share was -$0.39.

Revenue201.73M
Gross Profit 173.06M
Operating Income -123.40M
Pretax Income -135.93M
Net Income -135.93M
EBITDA -121.21M
EBIT -123.40M
Loss Per Share -$0.39
Full Income Statement

Balance Sheet

The company has $663.37 million in cash and $468.13 million in debt, with a net cash position of $195.25 million or $0.55 per share.

Cash & Cash Equivalents 663.37M
Total Debt 468.13M
Net Cash 195.25M
Net Cash Per Share $0.55
Equity (Book Value) 227.98M
Book Value Per Share 0.65
Working Capital 636.10M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$106.19 million and capital expenditures -$1.98 million, giving a free cash flow of -$108.17 million.

Operating Cash Flow -106.19M
Capital Expenditures -1.98M
Depreciation & Amortization 2.19M
Net Borrowing 218.05M
Free Cash Flow -108.17M
FCF Per Share -$0.31
Full Cash Flow Statement

Margins

Gross margin is 85.79%, with operating and profit margins of -61.17% and -67.38%.

Gross Margin 85.79%
Operating Margin -61.17%
Pretax Margin -67.38%
Profit Margin -67.38%
EBITDA Margin -60.09%
EBIT Margin -61.17%
FCF Margin n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -2.44%
Shareholder Yield -2.44%
Earnings Yield -10.17%
FCF Yield -7.98%

Analyst Forecast

The average price target for Nuvation Bio is $12.45, which is 224.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.45
Price Target Difference 224.22%
Analyst Consensus Strong Buy
Analyst Count 13
Revenue Growth Forecast (3Y) 86.04%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Nuvation Bio has an Altman Z-Score of 0.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.7
Piotroski F-Score 3